title: [Does obesity modify recurrence-free interval in breast cancer?].
authors.affiliation: I. Univers.-Frauenklinik Wien.
authors.forename: C
authors.initials: C
authors.lastname: Kurz
authors.forename: A
authors.initials: A
authors.lastname: Obermair
authors.forename: W
authors.initials: W
authors.lastname: Schemper
authors.forename: E
authors.initials: E
authors.lastname: Kubista
authors.forename: P
authors.initials: P
authors.lastname: Sevelda
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000401:mortality / Q000473:pathology / Q000628:therapy; D018275:Carcinoma, Lobular / Q000401:mortality / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000628:therapy; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000401:mortality / Q000473:pathology / Q000628:therapy; D009765:Obesity / Q000150:complications / Q000401:mortality* / Q000473:pathology; D011446:Prospective Studies; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012307:Risk Factors; D015996:Survival Rate
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
vernacular_title: Beeinflusst Adipositas das rezidivfreie Intervall beim Mammakarzinom?